English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Brain erythropoietin fine-tunes a counterbalance between neurodifferentiation and microglia in the adult hippocampus

Fernandez Garcia-Agudo, L., Steixner-Kumar, A. A., Curto, Y., Barnkothe, N., Hassouna, I., Jähne, S., et al. (2021). Brain erythropoietin fine-tunes a counterbalance between neurodifferentiation and microglia in the adult hippocampus. Cell Reports, 36: 109548. doi:10.1016/j.celrep.2021.109548.

Item is

Files

show Files
hide Files
:
3351772.pdf (Publisher version), 5MB
Name:
3351772.pdf
Description:
-
OA-Status:
Visibility:
Public
MIME-Type / Checksum:
application/pdf / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
-

Locators

show

Creators

show
hide
 Creators:
Fernandez Garcia-Agudo, L.1, Author           
Steixner-Kumar, A. A.1, Author           
Curto, Y.1, Author           
Barnkothe, N.1, Author           
Hassouna, Imam1, Author           
Jähne, S., Author
Butt, U. J.1, Author           
Grewe, K., Author
Weber, M. S., Author
Green, K., Author
Rizzoli, S., Author
Nacher, J., Author
Nave, K.-A.2, Author           
Ehrenreich, H.1, Author           
Affiliations:
1Clinical neuroscience, Max Planck Institute of Experimental Medicine, Max Planck Society, ou_2173651              
2Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society, ou_2173664              

Content

show
hide
Free keywords: Erythropoietin, neurodifferentiation, microglia
 Abstract: In adult cornu ammonis hippocampi, erythropoietin (EPO) expression drives the differentiation of new neurons,
independent of DNA synthesis, and increases dendritic spine density. This substantial brain hardware
upgrade is part of a regulatory circle: during motor-cognitive challenge, neurons experience ‘‘functional’’
hypoxia, triggering neuronal EPO production, which in turn promotes improved performance. Here, we
show an unexpected involvement of resident microglia. During EPO upregulation and stimulated neurodifferentiation,
either by functional or inspiratory hypoxia, microglia numbers decrease. Treating mice with recombinant
human (rh)EPO or exposure to hypoxia recapitulates these changes and reveals the involvement of
neuronally expressed IL-34 and microglial CSF1R. Surprisingly, EPO affects microglia in phases, initially
by inducing apoptosis, later by reducing proliferation, and overall dampens microglia activity and metabolism,
as verified by selective genetic targeting of either the microglial or pyramidal neuronal EPO receptor.
We suggest that during accelerating neuronal differentiation, EPO acts as regulator of the CSF1R-dependent
microglia.

Details

show
hide
Language(s): eng - English
 Dates: 2021-08-242021
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: DOI: 10.1016/j.celrep.2021.109548
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Cell Reports
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: 13 Volume / Issue: 36 Sequence Number: 109548 Start / End Page: - Identifier: ISSN: 22111247